You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Chemoradiation

Showing 26 - 50 of 1,748
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Esophagus Adenocarcinoma Trial in Frankfurt (Durvalumab, FLOT, mFOLFOX-6)

Not yet recruiting
  • Esophagus Adenocarcinoma
  • Frankfurt, Germany
    Institute of Clinical Cancer Research, University Cancer Center
Jan 26, 2023

Cervical Cancer Trial in Chengdu (NACT, CCRT, Brachytherapy)

Not yet recruiting
  • Cervical Cancer
  • Chengdu, Sichuan, China
    Sicchuan cancer hospital
Dec 28, 2021

Locally Advanced Pancreatic Cancer (LAPC) Trial in Herlev (Gemcitabine, Nab-paclitaxel, Nivolumab)

Recruiting
  • Borderline Resectable, Locally Advanced or Metastatic Pancreatic Cancer
  • Herlev, Denmark
    Herlev & Gentofte University Hospital, Denmark
Oct 13, 2022

Nonsmall Cell Lung Cancer Stage III, Unresectable Non-Small Cell Lung Carcinoma Trial in Winston-Salem (drug, other, diagnostic

Not yet recruiting
  • Nonsmall Cell Lung Cancer Stage III
  • Unresectable Non-Small Cell Lung Carcinoma
  • Winston-Salem, North Carolina
    Wake Forest Baptist Comprehensive Cancer Center
Jan 12, 2023

Locally Advanced Rectal Cancer Trial in Beijing (Long-course chemoradiation, with Tislelizumab (PD-1 inhibitor), Long-course

Recruiting
  • Locally Advanced Rectal Cancer
  • Long-course chemoradiation, with Tislelizumab (PD-1 inhibitor)
  • Long-course chemoradiation, without Tislelizumab (PD-1 inhibitor)
  • Beijing, Beijing, China
    Beijing Friendship Hospital, Capital Medical University
Apr 25, 2023

Esophageal Carcinoma, Neoadjuvant Chemoradiotherapy, Surgery Trial in Hangzhou (Higher dose (50.4Gy/28F) of neoadjuvant

Recruiting
  • Esophageal Carcinoma
  • +2 more
  • Higher dose (50.4Gy/28F) of neoadjuvant chemoradiation
  • Lower dose (41.4Gy/23F) of neoadjuvant chemoradiation
  • Hangzhou, Zhejiang, China
  • +1 more
Mar 12, 2022

Tumors, Esophageal Tumors, Esophagus Tumor Trial run by the National Cancer Institute (NCI) (Nivolumab, Entinostat, Montanide(R)

Not yet recruiting
  • Neoplasms
  • +5 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jun 16, 2023

High Grade Glioma Trial in Winston-Salem (procedure, diagnostic test, behavioral)

Recruiting
  • High Grade Glioma
  • PET-MRI Brain Scan
  • +3 more
  • Winston-Salem, North Carolina
    Wake Forest Baptist Comprehensive Cancer Center
Aug 5, 2022

Lymphoma Patients Undergoing Mediastinal Radiotherapy in Era of

Suspended
  • Mediastinal Lymphoma
  • +2 more
  • Standard treatment protocol with combined chemoradiation
  • Taoyuan, Taiwan
    Chang Gung Memorial Hospital
Mar 8, 2022

Nasopharyngeal Carcinoma Trial in Hangzhou, (Anlotinib HCl, induction chemo, concurrent chemoradiation)

Recruiting
  • Nasopharyngeal Carcinoma
  • Anlotinib hydrochloride
  • +2 more
  • Hangzhou,, Zhejiang, China
    Zhejiang Cancer Hospital
Jan 30, 2022

Resectable Esophageal Cancer, GastroEsophageal Cancer Trial in Madison (combination product, drug, radiation)

Active, not recruiting
  • Resectable Esophageal Cancer
  • GastroEsophageal Cancer
  • Avelumab combined with Chemoradiation
  • +3 more
  • Madison, Wisconsin
    University of Wisconsin Carbone Cancer Center
Mar 28, 2022

Cervical Cancer, Neoadjuvant Chemo, Bulky Tumor Trial in Guangzhou (Albumin-Bound Paclitaxel, Carboplatin)

Recruiting
  • Cervical Cancer
  • +2 more
  • Guangzhou, Guangdone, China
    Sun Yat-sen University Cancer Center
May 9, 2022

Squamous Cell Carcinoma, the Nasal Cavity, Paranasal Sinuses Trial in Houston (Pembrolizumab, Docetaxel, Cisplatin)

Recruiting
  • Squamous Cell Carcinoma
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Jul 10, 2022

Rectal Cancer Trial (Chemoradiation treatment, 18FDG-PET/MRI scan)

Not yet recruiting
  • Rectal Cancer
  • Chemoradiation treatment
  • 18FDG-PET/MRI scan
  • (no location specified)
Sep 26, 2023

Rectal Cancer Trial in Taipei (Surgery)

Recruiting
  • Rectal Cancer
  • Surgery
  • Taipei, Taiwan
    Jin-Tung LIANG
Jul 27, 2023

Esophageal Cancer, Esophagogastric Junction Cancer Trial in Lexington (drug, radiation, procedure)

Not yet recruiting
  • Esophageal Cancer
  • Esophagogastric Junction Cancer
  • Intravenous Tislelizumab
  • +3 more
  • Lexington, Kentucky
    University of Kentucky
Feb 21, 2022

Oropharyngeal Squamous Cell Carcinoma Trial in Saint Louis (CUE-101)

Recruiting
  • Oropharyngeal Squamous Cell Carcinoma
  • Saint Louis, Missouri
    Washington University School of Medicine
Nov 22, 2022

Adjuvant Chemoradiation of Gastric Carcinoma on Local Control

Not yet recruiting
  • Gastric Cancer
    • (no location specified)
    Mar 17, 2022

    Head and Neck Squamous Cell Carcinoma, Pain, Stomatitis Trial in Buffalo (Gabapentin, Methadone Hydrochloride, Oxycodone

    Completed
    • Head and Neck Squamous Cell Carcinoma
    • +2 more
    • Buffalo, New York
      Roswell Park Cancer Institute
    Jul 20, 2022

    Glioblastoma, Surgery, High Grade Glioma Trial in Danville, Wilkes-Barre (radiation, drug, procedure)

    Recruiting
    • Glioblastoma
    • +2 more
    • Neoadjuvant chemoradiation
    • +2 more
    • Danville, Pennsylvania
    • +1 more
    Jan 24, 2022

    Gastric Adenocarcinoma, Pancreatic Adenocarcinoma Trial in Houston (Aerobic Exercise, Dietary Intervention, Nutritional

    Withdrawn
    • Gastric Adenocarcinoma
    • Pancreatic Adenocarcinoma
    • Aerobic Exercise
    • +5 more
    • (no location specified)
    Oct 26, 2022

    Tumor, Rectum Trial (Total mesorectal excision before 56 days (4-8 weeks), Total mesorectal excision after 56 days (8-12 weeks))

    Completed
    Has Results
    • Neoplasm, Rectum
    • Total mesorectal excision before 56 days (4-8 weeks)
    • Total mesorectal excision after 56 days (8-12 weeks)
    • (no location specified)
    Mar 22, 2022

    Glioblastoma Trial in Camden, Houston (TH-1 Dendritic Cell Immunotherapy)

    Recruiting
    • Glioblastoma
    • TH-1 Dendritic Cell Immunotherapy
    • Camden, New Jersey
    • +1 more
    Jun 27, 2022

    Oropharyngeal Cancer, Squamous Cell Carcinoma of the Oropharynx Trial in Ann Arbor (procedure, combination product, other,

    Recruiting
    • Oropharyngeal Cancer
    • Squamous Cell Carcinoma of the Oropharynx
    • Surgery
    • +3 more
    • Ann Arbor, Michigan
      University of Michigan Rogel Cancer Center
    May 30, 2023

    Rectal Cancer Trial in Orange, Detroit, Saint Louis (Epacadostat, Tumor biopsy, Peripheral blood draw)

    Recruiting
    • Rectal Cancer
    • Orange, California
    • +2 more
    Jul 6, 2022